Global Transcatheter Mitral Valve Therapies (TMVT) Supply, Demand and Key Producers, 2026-2032
The global Transcatheter Mitral Valve Therapies (TMVT) market size is expected to reach $ 7724 million by 2032, rising at a market growth of 8.4% CAGR during the forecast period (2026-2032).
Transcatheter mitral valve therapies are minimally invasive structural heart devices used to treat mitral regurgitation and selected mitral valve abnormalities. They are delivered through transfemoral-transseptal, transapical or other catheter-based approaches under transesophageal echocardiography and fluoroscopic guidance to perform leaflet approximation, annular reduction, artificial chordal repair or full mitral valve replacement. These therapies primarily serve elderly, high-risk or surgery-ineligible patients by reducing procedural trauma and recovery burden while improving mitral regurgitation and cardiac function. In 2025, the global transcatheter mitral valve therapies market, measured by manufacturer revenue from implants and dedicated delivery systems, is estimated at about 135 k units, with the average selling price of around USD 32,000 per unit. The value chain of transcatheter mitral valve therapies starts with nitinol, cobalt-chromium alloys, stainless steel, PET/polyester fabrics, bovine or porcine pericardial tissue, polymer catheter materials, radiopaque materials, precision metal components and sterile packaging materials; midstream activities include the development, manufacturing, sterilization and regulatory registration of mitral clips, annuloplasty systems, chordal repair systems, replacement valves and delivery systems; downstream demand mainly comes from structural heart centers, tertiary hospitals with cardiology-surgery heart teams, cardiovascular specialty hospitals and patients with moderate-to-severe or severe mitral regurgitation.
The growth of the transcatheter mitral valve therapies market is primarily driven by the large mitral regurgitation patient pool, population aging, the expansion of heart-failure patients, the invasiveness of conventional surgery and the persistent undertreatment of high-risk patients. Historically, transcatheter mitral intervention progressed more slowly than TAVR because of complex mitral anatomy, non-circular annular geometry, variable leaflet and chordal structures, and the risk of left ventricular outflow tract obstruction. However, long-term clinical use of MitraClip has established physician confidence and reimbursement foundations, while newer repair systems such as PASCAL, DragonFly, NeoNova and SQ-Kyrin-M broaden product availability. Recent approvals of replacement systems such as SAPIEN M3, Tendyne and HighLife are creating new treatment options for patients unsuitable for TEER or surgery. As 3D TEE, CT planning, steerable delivery systems, leaflet grasping, anchoring designs and physician training mature, TMVT is expected to expand from a high-risk niche into a broader structural heart treatment pathway.
This report studies the global Transcatheter Mitral Valve Therapies (TMVT) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transcatheter Mitral Valve Therapies (TMVT) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transcatheter Mitral Valve Therapies (TMVT) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Transcatheter Mitral Valve Therapies (TMVT) total production and demand, 2021-2032, (K Units)
Global Transcatheter Mitral Valve Therapies (TMVT) total production value, 2021-2032, (USD Million)
Global Transcatheter Mitral Valve Therapies (TMVT) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Transcatheter Mitral Valve Therapies (TMVT) consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Transcatheter Mitral Valve Therapies (TMVT) domestic production, consumption, key domestic manufacturers and share
Global Transcatheter Mitral Valve Therapies (TMVT) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Transcatheter Mitral Valve Therapies (TMVT) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Transcatheter Mitral Valve Therapies (TMVT) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Transcatheter Mitral Valve Therapies (TMVT) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Edwards Lifesciences, HighLife SAS, Valgen Medtech, Hangzhou Dawneo, Shanghai Shenqi, Cardiac Dimensions, NeoChord, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transcatheter Mitral Valve Therapies (TMVT) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Transcatheter Mitral Valve Therapies (TMVT) Market, By Region:
1. How big is the global Transcatheter Mitral Valve Therapies (TMVT) market?
2. What is the demand of the global Transcatheter Mitral Valve Therapies (TMVT) market?
3. What is the year over year growth of the global Transcatheter Mitral Valve Therapies (TMVT) market?
4. What is the production and production value of the global Transcatheter Mitral Valve Therapies (TMVT) market?
5. Who are the key producers in the global Transcatheter Mitral Valve Therapies (TMVT) market?
6. What are the growth factors driving the market demand?
Transcatheter mitral valve therapies are minimally invasive structural heart devices used to treat mitral regurgitation and selected mitral valve abnormalities. They are delivered through transfemoral-transseptal, transapical or other catheter-based approaches under transesophageal echocardiography and fluoroscopic guidance to perform leaflet approximation, annular reduction, artificial chordal repair or full mitral valve replacement. These therapies primarily serve elderly, high-risk or surgery-ineligible patients by reducing procedural trauma and recovery burden while improving mitral regurgitation and cardiac function. In 2025, the global transcatheter mitral valve therapies market, measured by manufacturer revenue from implants and dedicated delivery systems, is estimated at about 135 k units, with the average selling price of around USD 32,000 per unit. The value chain of transcatheter mitral valve therapies starts with nitinol, cobalt-chromium alloys, stainless steel, PET/polyester fabrics, bovine or porcine pericardial tissue, polymer catheter materials, radiopaque materials, precision metal components and sterile packaging materials; midstream activities include the development, manufacturing, sterilization and regulatory registration of mitral clips, annuloplasty systems, chordal repair systems, replacement valves and delivery systems; downstream demand mainly comes from structural heart centers, tertiary hospitals with cardiology-surgery heart teams, cardiovascular specialty hospitals and patients with moderate-to-severe or severe mitral regurgitation.
The growth of the transcatheter mitral valve therapies market is primarily driven by the large mitral regurgitation patient pool, population aging, the expansion of heart-failure patients, the invasiveness of conventional surgery and the persistent undertreatment of high-risk patients. Historically, transcatheter mitral intervention progressed more slowly than TAVR because of complex mitral anatomy, non-circular annular geometry, variable leaflet and chordal structures, and the risk of left ventricular outflow tract obstruction. However, long-term clinical use of MitraClip has established physician confidence and reimbursement foundations, while newer repair systems such as PASCAL, DragonFly, NeoNova and SQ-Kyrin-M broaden product availability. Recent approvals of replacement systems such as SAPIEN M3, Tendyne and HighLife are creating new treatment options for patients unsuitable for TEER or surgery. As 3D TEE, CT planning, steerable delivery systems, leaflet grasping, anchoring designs and physician training mature, TMVT is expected to expand from a high-risk niche into a broader structural heart treatment pathway.
This report studies the global Transcatheter Mitral Valve Therapies (TMVT) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Transcatheter Mitral Valve Therapies (TMVT) and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Transcatheter Mitral Valve Therapies (TMVT) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Transcatheter Mitral Valve Therapies (TMVT) total production and demand, 2021-2032, (K Units)
Global Transcatheter Mitral Valve Therapies (TMVT) total production value, 2021-2032, (USD Million)
Global Transcatheter Mitral Valve Therapies (TMVT) production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Transcatheter Mitral Valve Therapies (TMVT) consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Transcatheter Mitral Valve Therapies (TMVT) domestic production, consumption, key domestic manufacturers and share
Global Transcatheter Mitral Valve Therapies (TMVT) production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Transcatheter Mitral Valve Therapies (TMVT) production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Transcatheter Mitral Valve Therapies (TMVT) production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Transcatheter Mitral Valve Therapies (TMVT) market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Edwards Lifesciences, HighLife SAS, Valgen Medtech, Hangzhou Dawneo, Shanghai Shenqi, Cardiac Dimensions, NeoChord, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Transcatheter Mitral Valve Therapies (TMVT) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Transcatheter Mitral Valve Therapies (TMVT) Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Edge-to-Edge Repair Systems
- Transcatheter Mitral Valve Replacement Systems
- Others
- Transfemoral-Transseptal Systems
- Transapical Systems
- Transvenous Coronary Sinus Systems
- Others
- Primary Mitral Regurgitation
- Secondary Mitral Regurgitation
- Others
- Cardiovascular Specialty Hospitals
- Tertiary General Hospitals
- Abbott Laboratories
- Edwards Lifesciences
- HighLife SAS
- Valgen Medtech
- Hangzhou Dawneo
- Shanghai Shenqi
- Cardiac Dimensions
- NeoChord
1. How big is the global Transcatheter Mitral Valve Therapies (TMVT) market?
2. What is the demand of the global Transcatheter Mitral Valve Therapies (TMVT) market?
3. What is the year over year growth of the global Transcatheter Mitral Valve Therapies (TMVT) market?
4. What is the production and production value of the global Transcatheter Mitral Valve Therapies (TMVT) market?
5. Who are the key producers in the global Transcatheter Mitral Valve Therapies (TMVT) market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Transcatheter Mitral Valve Therapies (TMVT) Introduction
1.2 World Transcatheter Mitral Valve Therapies (TMVT) Supply & Forecast
1.2.1 World Transcatheter Mitral Valve Therapies (TMVT) Production Value (2021 & 2025 & 2032)
1.2.2 World Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.2.3 World Transcatheter Mitral Valve Therapies (TMVT) Pricing Trends (2021-2032)
1.3 World Transcatheter Mitral Valve Therapies (TMVT) Production by Region (Based on Production Site)
1.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Region (2021-2032)
1.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production by Region (2021-2032)
1.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2021-2032)
1.3.4 North America Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.3.5 Europe Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.3.6 China Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.3.7 Japan Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transcatheter Mitral Valve Therapies (TMVT) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transcatheter Mitral Valve Therapies (TMVT) Major Market Trends
2 DEMAND SUMMARY
2.1 World Transcatheter Mitral Valve Therapies (TMVT) Demand (2021-2032)
2.2 World Transcatheter Mitral Valve Therapies (TMVT) Consumption by Region
2.2.1 World Transcatheter Mitral Valve Therapies (TMVT) Consumption by Region (2021-2026)
2.2.2 World Transcatheter Mitral Valve Therapies (TMVT) Consumption Forecast by Region (2027-2032)
2.3 United States Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.4 China Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.5 Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.6 Japan Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.7 South Korea Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.8 ASEAN Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.9 India Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Manufacturer (2021-2026)
3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production by Manufacturer (2021-2026)
3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Manufacturer (2021-2026)
3.4 Transcatheter Mitral Valve Therapies (TMVT) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transcatheter Mitral Valve Therapies (TMVT) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transcatheter Mitral Valve Therapies (TMVT) in 2025
3.5.3 Global Concentration Ratios (CR8) for Transcatheter Mitral Valve Therapies (TMVT) in 2025
3.6 Transcatheter Mitral Valve Therapies (TMVT) Market: Overall Company Footprint Analysis
3.6.1 Transcatheter Mitral Valve Therapies (TMVT) Market: Region Footprint
3.6.2 Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Type Footprint
3.6.3 Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Value Comparison
4.1.1 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Comparison
4.2.1 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Consumption Comparison
4.3.1 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2026)
4.5 China Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers and Market Share
4.5.1 China Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value (2021-2026)
4.5.3 China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2026)
4.6 Rest of World Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Transcatheter Mitral Valve Therapies (TMVT) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Edge-to-Edge Repair Systems
5.2.2 Transcatheter Mitral Valve Replacement Systems
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production by Type (2021-2032)
5.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type (2021-2032)
5.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ACCESS ROUTE
6.1 World Transcatheter Mitral Valve Therapies (TMVT) Market Size Overview by Access Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Access Route
6.2.1 Transfemoral-Transseptal Systems
6.2.2 Transapical Systems
6.2.3 Transvenous Coronary Sinus Systems
6.2.4 Others
6.3 Market Segment by Access Route
6.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production by Access Route (2021-2032)
6.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route (2021-2032)
6.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Access Route (2021-2032)
7 MARKET ANALYSIS BY DISEASE TYPE
7.1 World Transcatheter Mitral Valve Therapies (TMVT) Market Size Overview by Disease Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Disease Type
7.2.1 Primary Mitral Regurgitation
7.2.2 Secondary Mitral Regurgitation
7.2.3 Others
7.3 Market Segment by Disease Type
7.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production by Disease Type (2021-2032)
7.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type (2021-2032)
7.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Disease Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Transcatheter Mitral Valve Therapies (TMVT) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cardiovascular Specialty Hospitals
8.2.2 Tertiary General Hospitals
8.3 Market Segment by Application
8.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production by Application (2021-2032)
8.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application (2021-2032)
8.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Details
9.1.2 Abbott Laboratories Major Business
9.1.3 Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.1.4 Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Abbott Laboratories Recent Developments/Updates
9.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.2 Edwards Lifesciences
9.2.1 Edwards Lifesciences Details
9.2.2 Edwards Lifesciences Major Business
9.2.3 Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.2.4 Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Edwards Lifesciences Recent Developments/Updates
9.2.6 Edwards Lifesciences Competitive Strengths & Weaknesses
9.3 HighLife SAS
9.3.1 HighLife SAS Details
9.3.2 HighLife SAS Major Business
9.3.3 HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.3.4 HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 HighLife SAS Recent Developments/Updates
9.3.6 HighLife SAS Competitive Strengths & Weaknesses
9.4 Valgen Medtech
9.4.1 Valgen Medtech Details
9.4.2 Valgen Medtech Major Business
9.4.3 Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.4.4 Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Valgen Medtech Recent Developments/Updates
9.4.6 Valgen Medtech Competitive Strengths & Weaknesses
9.5 Hangzhou Dawneo
9.5.1 Hangzhou Dawneo Details
9.5.2 Hangzhou Dawneo Major Business
9.5.3 Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.5.4 Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Hangzhou Dawneo Recent Developments/Updates
9.5.6 Hangzhou Dawneo Competitive Strengths & Weaknesses
9.6 Shanghai Shenqi
9.6.1 Shanghai Shenqi Details
9.6.2 Shanghai Shenqi Major Business
9.6.3 Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.6.4 Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Shanghai Shenqi Recent Developments/Updates
9.6.6 Shanghai Shenqi Competitive Strengths & Weaknesses
9.7 Cardiac Dimensions
9.7.1 Cardiac Dimensions Details
9.7.2 Cardiac Dimensions Major Business
9.7.3 Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.7.4 Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Cardiac Dimensions Recent Developments/Updates
9.7.6 Cardiac Dimensions Competitive Strengths & Weaknesses
9.8 NeoChord
9.8.1 NeoChord Details
9.8.2 NeoChord Major Business
9.8.3 NeoChord Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.8.4 NeoChord Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 NeoChord Recent Developments/Updates
9.8.6 NeoChord Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Transcatheter Mitral Valve Therapies (TMVT) Industry Chain
10.2 Transcatheter Mitral Valve Therapies (TMVT) Upstream Analysis
10.2.1 Transcatheter Mitral Valve Therapies (TMVT) Core Raw Materials
10.2.2 Main Manufacturers of Transcatheter Mitral Valve Therapies (TMVT) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Transcatheter Mitral Valve Therapies (TMVT) Production Mode
10.6 Transcatheter Mitral Valve Therapies (TMVT) Procurement Model
10.7 Transcatheter Mitral Valve Therapies (TMVT) Industry Sales Model and Sales Channels
10.7.1 Transcatheter Mitral Valve Therapies (TMVT) Sales Model
10.7.2 Transcatheter Mitral Valve Therapies (TMVT) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Transcatheter Mitral Valve Therapies (TMVT) Introduction
1.2 World Transcatheter Mitral Valve Therapies (TMVT) Supply & Forecast
1.2.1 World Transcatheter Mitral Valve Therapies (TMVT) Production Value (2021 & 2025 & 2032)
1.2.2 World Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.2.3 World Transcatheter Mitral Valve Therapies (TMVT) Pricing Trends (2021-2032)
1.3 World Transcatheter Mitral Valve Therapies (TMVT) Production by Region (Based on Production Site)
1.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Region (2021-2032)
1.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production by Region (2021-2032)
1.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2021-2032)
1.3.4 North America Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.3.5 Europe Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.3.6 China Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.3.7 Japan Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Transcatheter Mitral Valve Therapies (TMVT) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Transcatheter Mitral Valve Therapies (TMVT) Major Market Trends
2 DEMAND SUMMARY
2.1 World Transcatheter Mitral Valve Therapies (TMVT) Demand (2021-2032)
2.2 World Transcatheter Mitral Valve Therapies (TMVT) Consumption by Region
2.2.1 World Transcatheter Mitral Valve Therapies (TMVT) Consumption by Region (2021-2026)
2.2.2 World Transcatheter Mitral Valve Therapies (TMVT) Consumption Forecast by Region (2027-2032)
2.3 United States Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.4 China Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.5 Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.6 Japan Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.7 South Korea Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.8 ASEAN Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
2.9 India Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Manufacturer (2021-2026)
3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production by Manufacturer (2021-2026)
3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Manufacturer (2021-2026)
3.4 Transcatheter Mitral Valve Therapies (TMVT) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Transcatheter Mitral Valve Therapies (TMVT) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Transcatheter Mitral Valve Therapies (TMVT) in 2025
3.5.3 Global Concentration Ratios (CR8) for Transcatheter Mitral Valve Therapies (TMVT) in 2025
3.6 Transcatheter Mitral Valve Therapies (TMVT) Market: Overall Company Footprint Analysis
3.6.1 Transcatheter Mitral Valve Therapies (TMVT) Market: Region Footprint
3.6.2 Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Type Footprint
3.6.3 Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Value Comparison
4.1.1 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Comparison
4.2.1 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Consumption Comparison
4.3.1 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value (2021-2026)
4.4.3 United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2026)
4.5 China Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers and Market Share
4.5.1 China Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value (2021-2026)
4.5.3 China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2026)
4.6 Rest of World Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Transcatheter Mitral Valve Therapies (TMVT) Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Edge-to-Edge Repair Systems
5.2.2 Transcatheter Mitral Valve Replacement Systems
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production by Type (2021-2032)
5.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type (2021-2032)
5.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY ACCESS ROUTE
6.1 World Transcatheter Mitral Valve Therapies (TMVT) Market Size Overview by Access Route: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Access Route
6.2.1 Transfemoral-Transseptal Systems
6.2.2 Transapical Systems
6.2.3 Transvenous Coronary Sinus Systems
6.2.4 Others
6.3 Market Segment by Access Route
6.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production by Access Route (2021-2032)
6.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route (2021-2032)
6.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Access Route (2021-2032)
7 MARKET ANALYSIS BY DISEASE TYPE
7.1 World Transcatheter Mitral Valve Therapies (TMVT) Market Size Overview by Disease Type: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Disease Type
7.2.1 Primary Mitral Regurgitation
7.2.2 Secondary Mitral Regurgitation
7.2.3 Others
7.3 Market Segment by Disease Type
7.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production by Disease Type (2021-2032)
7.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type (2021-2032)
7.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Disease Type (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Transcatheter Mitral Valve Therapies (TMVT) Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Cardiovascular Specialty Hospitals
8.2.2 Tertiary General Hospitals
8.3 Market Segment by Application
8.3.1 World Transcatheter Mitral Valve Therapies (TMVT) Production by Application (2021-2032)
8.3.2 World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application (2021-2032)
8.3.3 World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Abbott Laboratories
9.1.1 Abbott Laboratories Details
9.1.2 Abbott Laboratories Major Business
9.1.3 Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.1.4 Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Abbott Laboratories Recent Developments/Updates
9.1.6 Abbott Laboratories Competitive Strengths & Weaknesses
9.2 Edwards Lifesciences
9.2.1 Edwards Lifesciences Details
9.2.2 Edwards Lifesciences Major Business
9.2.3 Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.2.4 Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Edwards Lifesciences Recent Developments/Updates
9.2.6 Edwards Lifesciences Competitive Strengths & Weaknesses
9.3 HighLife SAS
9.3.1 HighLife SAS Details
9.3.2 HighLife SAS Major Business
9.3.3 HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.3.4 HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 HighLife SAS Recent Developments/Updates
9.3.6 HighLife SAS Competitive Strengths & Weaknesses
9.4 Valgen Medtech
9.4.1 Valgen Medtech Details
9.4.2 Valgen Medtech Major Business
9.4.3 Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.4.4 Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Valgen Medtech Recent Developments/Updates
9.4.6 Valgen Medtech Competitive Strengths & Weaknesses
9.5 Hangzhou Dawneo
9.5.1 Hangzhou Dawneo Details
9.5.2 Hangzhou Dawneo Major Business
9.5.3 Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.5.4 Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Hangzhou Dawneo Recent Developments/Updates
9.5.6 Hangzhou Dawneo Competitive Strengths & Weaknesses
9.6 Shanghai Shenqi
9.6.1 Shanghai Shenqi Details
9.6.2 Shanghai Shenqi Major Business
9.6.3 Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.6.4 Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Shanghai Shenqi Recent Developments/Updates
9.6.6 Shanghai Shenqi Competitive Strengths & Weaknesses
9.7 Cardiac Dimensions
9.7.1 Cardiac Dimensions Details
9.7.2 Cardiac Dimensions Major Business
9.7.3 Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.7.4 Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Cardiac Dimensions Recent Developments/Updates
9.7.6 Cardiac Dimensions Competitive Strengths & Weaknesses
9.8 NeoChord
9.8.1 NeoChord Details
9.8.2 NeoChord Major Business
9.8.3 NeoChord Transcatheter Mitral Valve Therapies (TMVT) Product and Services
9.8.4 NeoChord Transcatheter Mitral Valve Therapies (TMVT) Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 NeoChord Recent Developments/Updates
9.8.6 NeoChord Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Transcatheter Mitral Valve Therapies (TMVT) Industry Chain
10.2 Transcatheter Mitral Valve Therapies (TMVT) Upstream Analysis
10.2.1 Transcatheter Mitral Valve Therapies (TMVT) Core Raw Materials
10.2.2 Main Manufacturers of Transcatheter Mitral Valve Therapies (TMVT) Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Transcatheter Mitral Valve Therapies (TMVT) Production Mode
10.6 Transcatheter Mitral Valve Therapies (TMVT) Procurement Model
10.7 Transcatheter Mitral Valve Therapies (TMVT) Industry Sales Model and Sales Channels
10.7.1 Transcatheter Mitral Valve Therapies (TMVT) Sales Model
10.7.2 Transcatheter Mitral Valve Therapies (TMVT) Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Region (2021-2026)
Table 5. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Region (2027-2032)
Table 6. World Transcatheter Mitral Valve Therapies (TMVT) Production by Region (2021-2026) & (K Units)
Table 7. World Transcatheter Mitral Valve Therapies (TMVT) Production by Region (2027-2032) & (K Units)
Table 8. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Region (2021-2026)
Table 9. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Region (2027-2032)
Table 10. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Transcatheter Mitral Valve Therapies (TMVT) Major Market Trends
Table 13. World Transcatheter Mitral Valve Therapies (TMVT) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Transcatheter Mitral Valve Therapies (TMVT) Consumption by Region (2021-2026) & (K Units)
Table 15. World Transcatheter Mitral Valve Therapies (TMVT) Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Transcatheter Mitral Valve Therapies (TMVT) Producers in 2025
Table 18. World Transcatheter Mitral Valve Therapies (TMVT) Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Transcatheter Mitral Valve Therapies (TMVT) Producers in 2025
Table 20. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Transcatheter Mitral Valve Therapies (TMVT) Company Evaluation Quadrant
Table 22. World Transcatheter Mitral Valve Therapies (TMVT) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Transcatheter Mitral Valve Therapies (TMVT) Production Site of Key Manufacturer
Table 24. Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Type Footprint
Table 25. Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Application Footprint
Table 26. Transcatheter Mitral Valve Therapies (TMVT) Competitive Factors
Table 27. Transcatheter Mitral Valve Therapies (TMVT) New Entrant and Capacity Expansion Plans
Table 28. Transcatheter Mitral Valve Therapies (TMVT) Mergers & Acquisitions Activity
Table 29. United States VS China Transcatheter Mitral Valve Therapies (TMVT) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Transcatheter Mitral Valve Therapies (TMVT) Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Transcatheter Mitral Valve Therapies (TMVT) Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share (2021-2026)
Table 37. China Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share (2021-2026)
Table 42. Rest of World Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share (2021-2026)
Table 47. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Transcatheter Mitral Valve Therapies (TMVT) Production by Type (2021-2026) & (K Units)
Table 49. World Transcatheter Mitral Valve Therapies (TMVT) Production by Type (2027-2032) & (K Units)
Table 50. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Transcatheter Mitral Valve Therapies (TMVT) Production by Access Route (2021-2026) & (K Units)
Table 56. World Transcatheter Mitral Valve Therapies (TMVT) Production by Access Route (2027-2032) & (K Units)
Table 57. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route (2021-2026) & (USD Million)
Table 58. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route (2027-2032) & (USD Million)
Table 59. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Access Route (2021-2026) & (US$/Unit)
Table 60. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Access Route (2027-2032) & (US$/Unit)
Table 61. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Transcatheter Mitral Valve Therapies (TMVT) Production by Disease Type (2021-2026) & (K Units)
Table 63. World Transcatheter Mitral Valve Therapies (TMVT) Production by Disease Type (2027-2032) & (K Units)
Table 64. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type (2021-2026) & (USD Million)
Table 65. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type (2027-2032) & (USD Million)
Table 66. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Disease Type (2021-2026) & (US$/Unit)
Table 67. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Disease Type (2027-2032) & (US$/Unit)
Table 68. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Transcatheter Mitral Valve Therapies (TMVT) Production by Application (2021-2026) & (K Units)
Table 70. World Transcatheter Mitral Valve Therapies (TMVT) Production by Application (2027-2032) & (K Units)
Table 71. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 76. Abbott Laboratories Major Business
Table 77. Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 78. Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Abbott Laboratories Recent Developments/Updates
Table 80. Abbott Laboratories Competitive Strengths & Weaknesses
Table 81. Edwards Lifesciences Basic Information, Manufacturing Base and Competitors
Table 82. Edwards Lifesciences Major Business
Table 83. Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 84. Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Edwards Lifesciences Recent Developments/Updates
Table 86. Edwards Lifesciences Competitive Strengths & Weaknesses
Table 87. HighLife SAS Basic Information, Manufacturing Base and Competitors
Table 88. HighLife SAS Major Business
Table 89. HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 90. HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. HighLife SAS Recent Developments/Updates
Table 92. HighLife SAS Competitive Strengths & Weaknesses
Table 93. Valgen Medtech Basic Information, Manufacturing Base and Competitors
Table 94. Valgen Medtech Major Business
Table 95. Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 96. Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Valgen Medtech Recent Developments/Updates
Table 98. Valgen Medtech Competitive Strengths & Weaknesses
Table 99. Hangzhou Dawneo Basic Information, Manufacturing Base and Competitors
Table 100. Hangzhou Dawneo Major Business
Table 101. Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 102. Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Hangzhou Dawneo Recent Developments/Updates
Table 104. Hangzhou Dawneo Competitive Strengths & Weaknesses
Table 105. Shanghai Shenqi Basic Information, Manufacturing Base and Competitors
Table 106. Shanghai Shenqi Major Business
Table 107. Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 108. Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Shanghai Shenqi Recent Developments/Updates
Table 110. Shanghai Shenqi Competitive Strengths & Weaknesses
Table 111. Cardiac Dimensions Basic Information, Manufacturing Base and Competitors
Table 112. Cardiac Dimensions Major Business
Table 113. Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 114. Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Cardiac Dimensions Recent Developments/Updates
Table 116. Cardiac Dimensions Competitive Strengths & Weaknesses
Table 117. NeoChord Basic Information, Manufacturing Base and Competitors
Table 118. NeoChord Major Business
Table 119. NeoChord Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 120. NeoChord Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. NeoChord Recent Developments/Updates
Table 122. NeoChord Competitive Strengths & Weaknesses
Table 123. Global Key Players of Transcatheter Mitral Valve Therapies (TMVT) Upstream (Raw Materials)
Table 124. Global Transcatheter Mitral Valve Therapies (TMVT) Typical Customers
Table 125. Transcatheter Mitral Valve Therapies (TMVT) Typical Distributors
Table 1. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Region (2021-2026) & (USD Million)
Table 3. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Region (2027-2032) & (USD Million)
Table 4. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Region (2021-2026)
Table 5. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Region (2027-2032)
Table 6. World Transcatheter Mitral Valve Therapies (TMVT) Production by Region (2021-2026) & (K Units)
Table 7. World Transcatheter Mitral Valve Therapies (TMVT) Production by Region (2027-2032) & (K Units)
Table 8. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Region (2021-2026)
Table 9. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Region (2027-2032)
Table 10. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Transcatheter Mitral Valve Therapies (TMVT) Major Market Trends
Table 13. World Transcatheter Mitral Valve Therapies (TMVT) Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Transcatheter Mitral Valve Therapies (TMVT) Consumption by Region (2021-2026) & (K Units)
Table 15. World Transcatheter Mitral Valve Therapies (TMVT) Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Transcatheter Mitral Valve Therapies (TMVT) Producers in 2025
Table 18. World Transcatheter Mitral Valve Therapies (TMVT) Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Transcatheter Mitral Valve Therapies (TMVT) Producers in 2025
Table 20. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Transcatheter Mitral Valve Therapies (TMVT) Company Evaluation Quadrant
Table 22. World Transcatheter Mitral Valve Therapies (TMVT) Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Transcatheter Mitral Valve Therapies (TMVT) Production Site of Key Manufacturer
Table 24. Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Type Footprint
Table 25. Transcatheter Mitral Valve Therapies (TMVT) Market: Company Product Application Footprint
Table 26. Transcatheter Mitral Valve Therapies (TMVT) Competitive Factors
Table 27. Transcatheter Mitral Valve Therapies (TMVT) New Entrant and Capacity Expansion Plans
Table 28. Transcatheter Mitral Valve Therapies (TMVT) Mergers & Acquisitions Activity
Table 29. United States VS China Transcatheter Mitral Valve Therapies (TMVT) Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Transcatheter Mitral Valve Therapies (TMVT) Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Transcatheter Mitral Valve Therapies (TMVT) Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share (2021-2026)
Table 37. China Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share (2021-2026)
Table 42. Rest of World Based Transcatheter Mitral Valve Therapies (TMVT) Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share (2021-2026)
Table 47. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Transcatheter Mitral Valve Therapies (TMVT) Production by Type (2021-2026) & (K Units)
Table 49. World Transcatheter Mitral Valve Therapies (TMVT) Production by Type (2027-2032) & (K Units)
Table 50. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type (2021-2026) & (USD Million)
Table 51. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type (2027-2032) & (USD Million)
Table 52. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route, (USD Million), 2021 & 2025 & 2032
Table 55. World Transcatheter Mitral Valve Therapies (TMVT) Production by Access Route (2021-2026) & (K Units)
Table 56. World Transcatheter Mitral Valve Therapies (TMVT) Production by Access Route (2027-2032) & (K Units)
Table 57. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route (2021-2026) & (USD Million)
Table 58. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route (2027-2032) & (USD Million)
Table 59. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Access Route (2021-2026) & (US$/Unit)
Table 60. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Access Route (2027-2032) & (US$/Unit)
Table 61. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type, (USD Million), 2021 & 2025 & 2032
Table 62. World Transcatheter Mitral Valve Therapies (TMVT) Production by Disease Type (2021-2026) & (K Units)
Table 63. World Transcatheter Mitral Valve Therapies (TMVT) Production by Disease Type (2027-2032) & (K Units)
Table 64. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type (2021-2026) & (USD Million)
Table 65. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type (2027-2032) & (USD Million)
Table 66. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Disease Type (2021-2026) & (US$/Unit)
Table 67. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Disease Type (2027-2032) & (US$/Unit)
Table 68. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Transcatheter Mitral Valve Therapies (TMVT) Production by Application (2021-2026) & (K Units)
Table 70. World Transcatheter Mitral Valve Therapies (TMVT) Production by Application (2027-2032) & (K Units)
Table 71. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application (2021-2026) & (USD Million)
Table 72. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application (2027-2032) & (USD Million)
Table 73. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 76. Abbott Laboratories Major Business
Table 77. Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 78. Abbott Laboratories Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Abbott Laboratories Recent Developments/Updates
Table 80. Abbott Laboratories Competitive Strengths & Weaknesses
Table 81. Edwards Lifesciences Basic Information, Manufacturing Base and Competitors
Table 82. Edwards Lifesciences Major Business
Table 83. Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 84. Edwards Lifesciences Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Edwards Lifesciences Recent Developments/Updates
Table 86. Edwards Lifesciences Competitive Strengths & Weaknesses
Table 87. HighLife SAS Basic Information, Manufacturing Base and Competitors
Table 88. HighLife SAS Major Business
Table 89. HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 90. HighLife SAS Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. HighLife SAS Recent Developments/Updates
Table 92. HighLife SAS Competitive Strengths & Weaknesses
Table 93. Valgen Medtech Basic Information, Manufacturing Base and Competitors
Table 94. Valgen Medtech Major Business
Table 95. Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 96. Valgen Medtech Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Valgen Medtech Recent Developments/Updates
Table 98. Valgen Medtech Competitive Strengths & Weaknesses
Table 99. Hangzhou Dawneo Basic Information, Manufacturing Base and Competitors
Table 100. Hangzhou Dawneo Major Business
Table 101. Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 102. Hangzhou Dawneo Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Hangzhou Dawneo Recent Developments/Updates
Table 104. Hangzhou Dawneo Competitive Strengths & Weaknesses
Table 105. Shanghai Shenqi Basic Information, Manufacturing Base and Competitors
Table 106. Shanghai Shenqi Major Business
Table 107. Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 108. Shanghai Shenqi Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Shanghai Shenqi Recent Developments/Updates
Table 110. Shanghai Shenqi Competitive Strengths & Weaknesses
Table 111. Cardiac Dimensions Basic Information, Manufacturing Base and Competitors
Table 112. Cardiac Dimensions Major Business
Table 113. Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 114. Cardiac Dimensions Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Cardiac Dimensions Recent Developments/Updates
Table 116. Cardiac Dimensions Competitive Strengths & Weaknesses
Table 117. NeoChord Basic Information, Manufacturing Base and Competitors
Table 118. NeoChord Major Business
Table 119. NeoChord Transcatheter Mitral Valve Therapies (TMVT) Product and Services
Table 120. NeoChord Transcatheter Mitral Valve Therapies (TMVT) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. NeoChord Recent Developments/Updates
Table 122. NeoChord Competitive Strengths & Weaknesses
Table 123. Global Key Players of Transcatheter Mitral Valve Therapies (TMVT) Upstream (Raw Materials)
Table 124. Global Transcatheter Mitral Valve Therapies (TMVT) Typical Customers
Table 125. Transcatheter Mitral Valve Therapies (TMVT) Typical Distributors
LIST OF FIGURES
Figure 1. Transcatheter Mitral Valve Therapies (TMVT) Picture
Figure 2. World Transcatheter Mitral Valve Therapies (TMVT) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Transcatheter Mitral Valve Therapies (TMVT) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 5. World Transcatheter Mitral Valve Therapies (TMVT) Average Price (2021-2032) & (US$/Unit)
Figure 6. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Region (2021-2032)
Figure 7. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Region (2021-2032)
Figure 8. North America Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 9. Europe Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 10. China Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 11. Japan Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 12. Transcatheter Mitral Valve Therapies (TMVT) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 15. World Transcatheter Mitral Valve Therapies (TMVT) Consumption Market Share by Region (2021-2032)
Figure 16. United States Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 17. China Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 18. Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 19. Japan Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 20. South Korea Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 22. India Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Transcatheter Mitral Valve Therapies (TMVT) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Transcatheter Mitral Valve Therapies (TMVT) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Transcatheter Mitral Valve Therapies (TMVT) Markets in 2025
Figure 26. United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share 2025
Figure 30. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share 2025
Figure 32. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Type in 2025
Figure 34. Edge-to-Edge Repair Systems
Figure 35. Transcatheter Mitral Valve Replacement Systems
Figure 36. Others
Figure 37. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Type (2021-2032)
Figure 38. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Type (2021-2032)
Figure 39. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route, (USD Million), 2021 & 2025 & 2032
Figure 41. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Access Route in 2025
Figure 42. Transfemoral-Transseptal Systems
Figure 43. Transapical Systems
Figure 44. Transvenous Coronary Sinus Systems
Figure 45. Others
Figure 46. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Access Route (2021-2032)
Figure 47. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Access Route (2021-2032)
Figure 48. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Access Route (2021-2032) & (US$/Unit)
Figure 49. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type, (USD Million), 2021 & 2025 & 2032
Figure 50. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Disease Type in 2025
Figure 51. Primary Mitral Regurgitation
Figure 52. Secondary Mitral Regurgitation
Figure 53. Others
Figure 54. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Disease Type (2021-2032)
Figure 55. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Disease Type (2021-2032)
Figure 56. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Disease Type (2021-2032) & (US$/Unit)
Figure 57. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Application in 2025
Figure 59. Cardiovascular Specialty Hospitals
Figure 60. Tertiary General Hospitals
Figure 61. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Application (2021-2032)
Figure 62. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Application (2021-2032)
Figure 63. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Transcatheter Mitral Valve Therapies (TMVT) Industry Chain
Figure 65. Transcatheter Mitral Valve Therapies (TMVT) Procurement Model
Figure 66. Transcatheter Mitral Valve Therapies (TMVT) Sales Model
Figure 67. Transcatheter Mitral Valve Therapies (TMVT) Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
Figure 1. Transcatheter Mitral Valve Therapies (TMVT) Picture
Figure 2. World Transcatheter Mitral Valve Therapies (TMVT) Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Transcatheter Mitral Valve Therapies (TMVT) Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 5. World Transcatheter Mitral Valve Therapies (TMVT) Average Price (2021-2032) & (US$/Unit)
Figure 6. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Region (2021-2032)
Figure 7. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Region (2021-2032)
Figure 8. North America Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 9. Europe Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 10. China Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 11. Japan Transcatheter Mitral Valve Therapies (TMVT) Production (2021-2032) & (K Units)
Figure 12. Transcatheter Mitral Valve Therapies (TMVT) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 15. World Transcatheter Mitral Valve Therapies (TMVT) Consumption Market Share by Region (2021-2032)
Figure 16. United States Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 17. China Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 18. Europe Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 19. Japan Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 20. South Korea Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 22. India Transcatheter Mitral Valve Therapies (TMVT) Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Transcatheter Mitral Valve Therapies (TMVT) by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Transcatheter Mitral Valve Therapies (TMVT) Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Transcatheter Mitral Valve Therapies (TMVT) Markets in 2025
Figure 26. United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Transcatheter Mitral Valve Therapies (TMVT) Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share 2025
Figure 30. China Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Transcatheter Mitral Valve Therapies (TMVT) Production Market Share 2025
Figure 32. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Type in 2025
Figure 34. Edge-to-Edge Repair Systems
Figure 35. Transcatheter Mitral Valve Replacement Systems
Figure 36. Others
Figure 37. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Type (2021-2032)
Figure 38. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Type (2021-2032)
Figure 39. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Access Route, (USD Million), 2021 & 2025 & 2032
Figure 41. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Access Route in 2025
Figure 42. Transfemoral-Transseptal Systems
Figure 43. Transapical Systems
Figure 44. Transvenous Coronary Sinus Systems
Figure 45. Others
Figure 46. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Access Route (2021-2032)
Figure 47. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Access Route (2021-2032)
Figure 48. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Access Route (2021-2032) & (US$/Unit)
Figure 49. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Disease Type, (USD Million), 2021 & 2025 & 2032
Figure 50. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Disease Type in 2025
Figure 51. Primary Mitral Regurgitation
Figure 52. Secondary Mitral Regurgitation
Figure 53. Others
Figure 54. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Disease Type (2021-2032)
Figure 55. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Disease Type (2021-2032)
Figure 56. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Disease Type (2021-2032) & (US$/Unit)
Figure 57. World Transcatheter Mitral Valve Therapies (TMVT) Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Application in 2025
Figure 59. Cardiovascular Specialty Hospitals
Figure 60. Tertiary General Hospitals
Figure 61. World Transcatheter Mitral Valve Therapies (TMVT) Production Market Share by Application (2021-2032)
Figure 62. World Transcatheter Mitral Valve Therapies (TMVT) Production Value Market Share by Application (2021-2032)
Figure 63. World Transcatheter Mitral Valve Therapies (TMVT) Average Price by Application (2021-2032) & (US$/Unit)
Figure 64. Transcatheter Mitral Valve Therapies (TMVT) Industry Chain
Figure 65. Transcatheter Mitral Valve Therapies (TMVT) Procurement Model
Figure 66. Transcatheter Mitral Valve Therapies (TMVT) Sales Model
Figure 67. Transcatheter Mitral Valve Therapies (TMVT) Sales Channels, Direct Sales, and Distribution
Figure 68. Methodology
Figure 69. Research Process and Data Source
